Skip to main content
main-content

Research news from the Virtual EASD Annual Meeting 2020

Research news from the Virtual EASD Annual Meeting 2020

09-22-2020 | EASD 2020 | Conference coverage | News

Screening could give 2 years’ extra type 2 diabetes treatment time

Screening of people aged 40 to 70 years using glycated hemoglobin would detect type 2 diabetes approximately 2 years earlier than when it is identified due to symptoms or incidental diagnosis, suggests an analysis of the UK Biobank.

09-22-2020 | EASD 2020 | Conference coverage | News

Dementia–type 2 diabetes link driven mostly by vascular risk

The increased risk for dementia associated with type 2 diabetes is strongest for vascular dementia, researchers have reported at the virtual 56th EASD Annual Meeting.

09-22-2020 | EASD 2020 | Conference coverage | News

Time in range predicts microvascular complication risk in type 1 diabetes

Among people with type 1 diabetes using continuous glucose monitoring, shorter time in range is associated with an increased risk for microvascular complications, suggests an analysis of data from the RESCUE trial.

09-23-2020 | EASD 2020 | Conference coverage | News

Novel oral insulin shows promise for type 2 diabetes